As a pharmacist, I want to add some clinical context to this discussion on Uric acid trends on GLP-1 anyone have.
Building on what Dr.PulmRoch said — the evidence base here is robust. The key publications to reference are from the SURMOUNT program[1].
Key clinical points:
- Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
- Side effect profile is predictable and usually manageable with standard protocols
- Monitoring should include baseline labs and follow-up at 3-month intervals
- Patient education significantly improves outcomes and adherence
Standard disclaimer: this is educational, not individualized medical advice.
[1] See thread title for relevant study identification.
Reading this thread on Uric acid trends on GLP-1 hits close to home. Dad of 2 checking in — I started at 277 lbs and felt like I would tried everything.
13 months on tirz and I am a different person. Not just the 52 lbs lost — my energy, my mood, my relationship with food. All transformed.
If you are on the fence about Uric acid trends on — take the leap. It was the best health decision I have ever made. ❤️
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsDr.LipidDallas — that is really helpful context on Uric acid trends on GLP-1. Follow-up question: how long did you wait before increasing your dose?
I am in a similar situation (week 4) and trying to set realistic expectations.
To answer SallyK_inj's question specifically:
From a clinical standpoint, Uric acid trends on GLP-1 is a reasonable concern that deserves a thorough answer.
The short answer: the evidence supports this approach for most patients.
The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.